However, inhibition of this classical secretory route via endoplasmic reticulum (ER) and Golgi apparatus using brefeldin A and monensin could not prevent or impair YB-1 release from different melanoma cell lines (Figure 2a; Figure S3a). Here, YBX1 is linked to melanoma.